Study guide
20.4 Laboratory Mathematics and Instrumentation
Scientist in Blood Banking, BB ASCP
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility Routes and Application 1.3 CMP, Credential Citation, and BB vs SBB
2 Donors and Collection
2.1 Donor Qualification 2.2 Collection Methods and Adverse Reactions 2.3 Special Donations
3 Processing, Storage, and Component QC
3.1 Processing: FDA/AABB Requirements, Testing, and Labeling 3.2 Anticoagulants, Additives, and Storage Temperatures 3.3 Transportation, Stored-Product Properties, and Expiration 3.4 Blood Component Quality Control
4 Blood Components
4.1 Red Blood Cells, Whole Blood, Washed, Frozen, and Rejuvenated 4.2 Platelets, Plasma, and Cryoprecipitated AHF 4.3 Granulocytes, Leukoreduced, and Irradiated Components 4.4 Apheresis Products, Fractionation, and Hematopoietic Progenitors
5 Blood Group Genetics and Transfusion Role
5.1 Basic and Molecular Genetics 5.2 Inheritance of Blood Groups 5.3 Immunogenicity and Antigen Prevalence
6 ABO and Lewis Systems
6.1 ABO Biochemistry and Antigens 6.2 ABO Antibodies, Discrepancies, and Subgroups 6.3 Lewis System
7 Rh System
7.1 Rh Genetics and Antigens 7.2 Weak D, Partial D, and Rh Antibodies 7.3 Rh Phenotyping and Clinical Significance
8 Kell, Duffy, Kidd, and MNS
8.1 Kell System 8.2 Duffy System 8.3 Kidd System 8.4 MNS System
9 Additional Systems and Antigens
9.1 P1PK, Globoside, and Ii Systems 9.2 Lutheran and Other Blood Group Systems 9.3 High- and Low-Prevalence Antigens 9.4 HLA, Platelet-Specific, and Granulocyte-Specific Antigens
10 Immunology Foundations
10.1 Immune Response, B and T Cells, Macrophages 10.2 Immunoglobulins: Classes, Structure, and Properties 10.3 Antigen-Antibody Interactions and Testing 10.4 Complement Pathways and Biologic Properties
11 Physiology, Hemostasis, Cytopenias, and Transplantation
11.1 Physiology of Blood 11.2 Hemostasis and Coagulation 11.3 Immune and Nonimmune Cytopenias 11.4 Solid Organ and HPC Transplantation
12 Hemolytic Disease of the Fetus and Newborn
12.1 HDFN Pathophysiology 12.2 HDFN Detection 12.3 HDFN Treatment and Prevention
13 Routine Serologic Testing
13.1 Blood Grouping Tests 13.2 Antibody Detection 13.3 Compatibility Testing and Crossmatch 13.4 Direct Antiglobulin Testing
14 Antibody Identification
14.1 Antibody Identification and Rule-Out 14.2 Clinical Significance, Dosage, and Multiple Antibodies 14.3 Panel Problem-Solving and Common Traps
15 Reagents and Special Techniques
15.1 Antiglobulin Sera, Grouping Sera, and Reagent Red Cells 15.2 Enzymes, Enhancement Media, and Lectins 15.3 Adsorption, Elution, Titration, and Cell Separations 15.4 Molecular, Solid-Phase, Column, ELISA, and Related Methods
16 Serologic QA and Special Reagents
16.1 Blood Sample Quality Assurance 16.2 Reagent and Procedure Quality Assurance 16.3 Thiol Reagents, Neutralization, Chloroquine, EGA, and Immunofluorescence
17 Indications and Component Therapy
17.1 Indications for Transfusion 17.2 Red Cell and Whole Blood Therapy 17.3 Platelet, Plasma, and Cryoprecipitate Therapy 17.4 Special Component Therapy
18 Adverse Effects of Transfusion
18.1 Immunologic Transfusion Reactions 18.2 Nonimmunologic Transfusion Reactions 18.3 Transfusion-Transmitted Diseases
19 Apheresis, Administration, and Patient Blood Management
19.1 Apheresis and Extracorporeal Circulation 19.2 Blood Administration 19.3 Patient Blood Management
20 Laboratory Operations
20.1 Quality Assessment and Troubleshooting 20.2 Quality Control, Proficiency Testing, and Regulation 20.3 Laboratory Safety 20.4 Laboratory Mathematics and Instrumentation
20.4 Laboratory Mathematics and Instrumentation
Key Takeaways Explain This Topic AI
RhIG vials: fetal whole-blood mL = (KB% / 100) × maternal blood volume (use 5,000 mL if not stated); divide by 30; apply the stem’s rounding rule; add 1 safety vial. One 300 µg vial covers 30 mL whole blood or 15 mL packed red cells.
A stable 70 kg adult rises about 1 g/dL hemoglobin (3% hematocrit) per RBC unit. Units to screen = units needed ÷ (product of antigen-negative frequencies).
CCI = (post − pre platelet count per µL × BSA in m²) / (platelets transfused × 10^11). A 10–60 minute CCI below about 5000–7500 on two occasions points to immune refractoriness (Chapter 17.3).
Instrument QC is daily function plus periodic calibration: serofuge timer/speed/function, cell-washer residual saline, 37 °C heat block, microscope mixed-field reading rules, irradiator dose mapping (25 Gy midplane, ≥15 Gy everywhere) plus an indicator that only proves the unit went into the device.
Gel and solid-phase analyzers need manufacturer QC each day of use and a tube-method reflex path for mixed-field, ABO subgroups, and interpretations the camera cannot make.
Last updated: August 2026
20.4 Laboratory Mathematics and Instrumentation
Quick Answer: RhIG vials = (KB% / 100 × maternal blood volume) / 30 , then round by the stem’s rule and add 1 . Default maternal volume is 5,000 mL . One 300 µg vial covers 30 mL whole blood . One RBC unit raises a stable 70 kg adult about 1 g/dL Hb ( 3% Hct ). Units to screen = units needed / antigen-negative frequency. CCI uses BSA and dose × 10^11 . Instruments: serofuge, cell washer, 37 °C block, microscope, irradiator, automated analyzer — each with QC.
The June 9, 2026 outline puts VI.C Laboratory mathematics and VI.D Instrumentation together. Chapter 12.3 already ran one postpartum RhIG stem; Chapter 17.3 already defined CCI for refractoriness. This section is the general math toolkit and the boxes on the bench .
RhIG vials from a Kleihauer–Betke
One 300 µg (1500 IU) vial of Rh immune globulin neutralizes about 30 mL of D-positive whole blood or 15 mL of packed red cells . A 50 µg microdose is an early-pregnancy dose in some protocols, not the term FMH dose.
Fetal whole blood (mL) = (KB percent / 100) × maternal blood volume (mL).
If the stem omits blood volume, use 5,000 mL . That shortcut is FMH (mL) = KB% × 50 .
Vials to cover the bleed = FMH / 30.
Then apply rounding and add 1 safety vial .
AABB-style rounding (use this unless the stem gives another rule): look at the decimal after dividing by 30. If it is < 0.5 , round down ; if it is ≥ 0.5 , round up . Then add 1. Some stems say only “round up and add 1” — obey the stem. An already-whole number (3.0) just gets the extra vial (4).
Worked examples (volume 5,000 mL):
- KB% FMH calculation FMH / 30 AABB round +1 vial
- 1.2% 0.012 × 5,000 = 60 mL 2.00 2 3
- 1.8% 0.018 × 5,000 = 90 mL 3.00 3 4
- 2.1% 0.021 × 5,000 = 105 mL 3.50 4 (0.5 rounds up) 5
- 2.6% 0.026 × 5,000 = 130 mL 4.33 4 (< 0.5 down) 5
Flow cytometry / immunofluorescence FMH assays report mL of fetal red cells or a percent; convert to the same 30 mL whole-blood coverage before you add the safety vial. After RhIG the mother may type as weak D and the screen may show anti-D — do not call her D-positive and do not withhold the postpartum dose (Chapter 12.3).
Expected hemoglobin increment, units to screen, CCI, and conversions
Red-cell increment. In a stable ~70 kg adult who is not bleeding or hemolyzing, 1 RBC unit raises hemoglobin about 1 g/dL and hematocrit about 3% . A patient whose Hb is 6.8 g/dL and whose target is 9.8 g/dL needs about 3 units if those assumptions hold. Failure to increment is bleeding, hypersplenism, or hemolysis (including a delayed serologic/hemolytic reaction), not a reason to keep issuing the same type blindly. Pediatrics: 10–15 mL/kg packed red cells typically raises Hb about 2–3 g/dL . Do not apply the 1 g/dL adult rule to a 12 kg toddler.
Units to screen.
Number of units to screen = units needed / (antigen-negative frequency).
For several alloantibodies, multiply the antigen-negative frequencies if the antigens assort independently (the usual exam assumption). Use the Caucasian teaching frequencies unless the stem gives another population.
Common antigen-negative frequencies (Caucasian teaching set): K-neg 0.91 , E-neg 0.70 , c-neg 0.20 , C-neg 0.30 , e-neg 0.02 , Fya-neg 0.34 , Jka-neg 0.23 , S-neg 0.45 .
Need 2 units for a patient with anti-E and anti-K:
0.70 × 0.91 = 0.637 .
2 / 0.637 = 3.14 → screen at least 4 units.
Need 3 units for anti-c and anti-K:
0.20 × 0.91 = 0.182 .
3 / 0.182 = 16.5 → screen 17 units (and call the reference lab / rare-donor program rather than antigen-type your entire inventory at 02:00).
CCI (conceptual). Chapter 17.3 is the clinical home. Formula for this math section:
CCI = [(post − pre platelet count per µL) × BSA (m²)] / (platelets transfused × 10^11)
A 10–60 minute CCI < 5000–7500 on two occasions supports immune refractoriness. A single low 24-hour count is survival , not a one-hour increment. You need the labeled yield; “one apheresis bag” is not a number.
Conversions and percent solutions. 1 dL = 100 mL, so Hb 8 g/dL = 80 g/L. 37 °C = 98.6 °F; 1–6 °C storage is 33.8–42.8 °F. Weight/volume percent is grams per 100 mL: 0.9% NaCl = 0.9 g/100 mL = 9 g/L . Dilutions use C1V1 = C2V2 . To make 250 mL of 5% albumin from 25% albumin: 25 × V1 = 5 × 250 → V1 = 50 mL of 25% plus 200 mL diluent. Do not treat a 5% bottle as if it were 25% just because both say “albumin.”
Instrumentation and instrument QC
Serologic centrifuge (serofuge). Immediate-spin, wash, and AHG buttons need different times . QC: timer accuracy, speed / RCF with a tachometer, and function (a known weakly positive cell still buttons and resuspends as the SOP describes). An extra 15 seconds is not “safer” — it can pack rouleaux into a fake agglutinate or change a calibrated IS ABO. Failed QC takes the head out of service (Chapter 16.2 / 20.1).
Cell washer. Automated saline fills and decants before AHG. QC the fill volume and the residual saline left after the last decant. Too much leftover saline dilutes AHG and causes false-negative IAT. Too little wash leaves unbound IgG and wastes AHG on leftover protein. A washer that “sounds normal” is not QC.
37 °C incubator / heat block. Daily thermometer check, usually 36–38 °C . A heat-block well can read 34 °C while the display says 37 °C — measure the well you actually use. Antibody screens incubated cold miss warm alloantibodies; overheated wells can hemolyze or cook complement.
Microscope. Use it when the SOP says so: mixed-field ABO (recent transfusion, A3, chimera, HPC transplant), distinguishing rouleaux from true agglutination, and immunofluorescence / FMH slides. Autofluorescence on an FMH slide can mimic a fetal cell if the filter set or quenching step is wrong — that is an instrumentation limitation, not extra FMH. Many modern SOPs forbid microscopic reading of antibody screens because it inflates false positives. If the stem says the tech read a 1+ screen only under oil, ask whether the SOP allowed it.
Irradiator. Cesium-137 or X-ray. Target dose is 25 Gy (2500 cGy) to the midplane of the canister, with no point < 15 Gy . Upper limits (often 50 Gy ) protect the red-cell membrane. Dose mapping at installation and at defined intervals proves the field. The irradiation indicator on the bag only shows the unit entered a radiation field . It is not a personal dosimeter and it does not prove 25 Gy reached the midplane. QC: indicator on every irradiated unit, dose map current, turntable / cycle complete, and the DIN in the irradiator log. A unit with an unchanged indicator is not irradiated, even if someone “is sure it went in.”
Automated immunohematology analyzer (gel / column agglutination or solid-phase red-cell adherence). These are the Vision / Erytra-class columns and the solid-phase well systems. They give reproducible IAT and are the engine of reflex panels. Limitations you must be able to name:
Mixed-field and some ABO subgroups are easy for a camera to under-call.
Rouleaux , cold autoantibodies, and hemolysis need a human and often a tube reflex .
Solid-phase can look “positive” with some warm autoantibodies and some HLA-ish noise; gel can miss some weak ABO isoagglutinins if the card and the sample are a mismatch.
The analyzer does not replace an emergency group O decision while a discrepancy algorithm is running.
Analyzer QC: manufacturer-required controls each day of use , calibration/maintenance per the file, comparison with tube during validation, and a written reflex SOP. Do not report a patient type the instrument flagged as invalid just because the previous 40 types were fine.
- Instrument Core QC Typical failure mode on the exam
- Serofuge Timer, speed/RCF, function False IS ABO or packed rouleaux
- Cell washer Fill volume, residual saline False-negative AHG
- 37 °C block Daily thermometer, 36–38 °C Missed warm alloantibody
- Microscope SOP-defined use; dirty optics / autofluorescence Fake FMH or over-read screen
- Irradiator Dose map 25 Gy / ≥15 Gy; indicator + log TA-GVHD risk if under-dosed
- Gel / solid-phase analyzer Daily manufacturer QC; tube reflex Missed mixed-field or ABO subgroup